Results 231 to 240 of about 11,284,409 (311)

Maternal nutrition as a key determinant of placental and developing blood–brain barrier xenobiotic protective functions

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Suboptimal maternal nutrition alters placental and developing blood–brain barrier (BBB) protective function and is associated with increased fetal brain vulnerability. In the placenta, nutritional adversity may reduce the exchange surface area and promote meta‐inflammation, compromising barrier efficiency in a model‐ and context ...
Kristin L. Connor   +4 more
wiley   +1 more source

Interplay of defects and dopants in <i>l</i>-Dopa -aided UiO-66 for superprotonic conductivity. [PDF]

open access: yesRSC Adv
Selvakumar P   +6 more
europepmc   +1 more source

Comparative Analysis of Chemical Composition and Bioactivities of Essential Oils From Different Parts of Wild‐Grown Alpinia siamensis K.Schum. in Vietnam

open access: yesChemistry &Biodiversity, Volume 23, Issue 9, September 2026.
The essential oils of Alpinia siamensis are rich in β‐bisabolene, 1,8‐cineole, and β‐pinene. These essential oils inhibit α‐amylase and tyrosinase and also suppress the growth of Escherichia coli and Bacillus subtilis. ABSTRACT This study investigated chemical composition and bioactivities of essential oils (EOs) obtained from the rhizomes (REO ...
Nguyen Thi Kim Anh   +8 more
wiley   +1 more source

L-Dopa-induced changes in aperiodic bursts dynamics relate to individual clinical improvement in Parkinson's disease. [PDF]

open access: yesNPJ Parkinsons Dis
Agouram H   +11 more
europepmc   +1 more source

Moringa oleifera Lam. Seed Lectin (WSMoL) Attenuates Parkinsonian Symptoms in Mice via Anti‐Inflammatory, Antioxidant, and Neurotransmitter‐Modulating Effects

open access: yesChemistry &Biodiversity, Volume 23, Issue 9, September 2026.
WSMoL attenuates motor impairment, neuroinflammation, oxidative stress, and monoamine depletion in a rotenone‐induced model of Parkinson's disease. The involvement of D1 receptor‐mediated signaling is demonstrated, providing new insights into the mechanisms underlying its neuroprotective effects and supporting WSMoL as a promising candidate for further
Leydianne Leite de Siqueira Patriota   +14 more
wiley   +1 more source

Advancing Type 1 Diabetes Treatment: 3 PM‐Oriented Innovations in Islet Transplantation and Biomaterial Engineering

open access: yesDiabetes/Metabolism Research and Reviews, Volume 42, Issue 6, September 2026.
ABSTRACT Type 1 Diabetes (T1D) is an autoimmune disorder marked by the immune‐mediated destruction of pancreatic β‐cells, resulting in insulin deficiency and dysregulated glucose control. Current therapies—such as insulin replacement and artificial pancreas systems—manage symptoms but fail to restore endogenous β‐cell function or halt disease ...
Fatemeh Sabet Sarvestani   +4 more
wiley   +1 more source

Behavioral Phenotyping of the Pahenu2 Mouse Model for Phenylketonuria—A Scoping Review and Future Perspectives

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 5, September 2026.
ABSTRACT Phenylketonuria (PKU) is a rare metabolic disorder resulting from a mutation in the gene encoding the enzyme phenylalanine hydroxylase (PAH), resulting in very high phenylalanine (Phe) levels in blood and brain. A PKU mutant mouse model was developed via N‐ethyl‐N‐nitrosourea (ENU) mutagenesis, mimicking the high brain Phe content seen in ...
Junfei Cao   +5 more
wiley   +1 more source

L-DOPA Induces Spatially Discrete Changes in Gene Expression in the Forebrain of Mice with a Progressive Loss of Dopaminergic Neurons. [PDF]

open access: yesMol Neurobiol
Radlicka-Borysewska A   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy